Endothelin receptors as a potential therapeutic target in the treatment of cardiovascular disease: Rationale for selective antagonism of the ET(A) subtype

被引：0
作者：
Webb, ML
Liu, ECK
Aversa, CR
Spinale, FG
Russell, ME
机构：
[1] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT CARDIOVASC BIOCHEM,PRINCETON,NJ 08543
[2] MED UNIV S CAROLINA,DIV CARDIOTHORAC SURG,CHARLESTON,SC 29425
[3] HARVARD UNIV,BRIGHAM & WOMENS HOSP,DEPT MED,SCH MED,BOSTON,MA 02115
来源：
DRUG NEWS & PERSPECTIVES | 1996年 / 9卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：348 / 350
页数：3
相关论文
共 50 条
  • [21] Therapeutic potential of tucidinostat, a subtype-selective HDAC inhibitor, in cancer treatment
    Sun, Yichen
    Hong, Jing Han
    Ning, Zhiqiang
    Pan, Desi
    Fu, Xin
    Lu, Xianping
    Tan, Jing
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [22] The Prevalence of Cardiovascular Disease in Patients With Von Willebrand Disease; A Potential Therapeutic Target
    Mihyawi, Nawfal
    Ajmal, Muhammad
    Hung, Jun
    Yeneneh, Beeletsega T.
    CIRCULATION, 2020, 142
  • [23] Fibrin is a potential therapeutic target for the treatment of inflammatory disease
    Nature Clinical Practice Rheumatology, 2008, 4 (2): : 63 - 64
  • [24] Advanced glycation endproduct crosslinking in the cardiovascular system - Potential therapeutic target for cardiovascular disease
    Zieman, SJ
    Kass, DA
    DRUGS, 2004, 64 (05) : 459 - 470
  • [25] miR-29 family: A potential therapeutic target for cardiovascular disease
    Liu, Meng-Nan
    Luo, Gang
    Gao, Wan-Jiao
    Yang, Si-Jin
    Zhou, Hua
    PHARMACOLOGICAL RESEARCH, 2021, 166
  • [26] Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
    Belli, Martina
    Barone, Lucy
    Longo, Susanna
    Prandi, Francesca Romana
    Lecis, Dalgisio
    Mollace, Rocco
    Margonato, Davide
    Muscoli, Saverio
    Sergi, Domenico
    Federici, Massimo
    Barilla, Francesco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [27] SUBTYPE-SELECTIVE MUSCARINIC AGONISTS - POTENTIAL THERAPEUTIC AGENTS FOR ALZHEIMERS-DISEASE
    DAVIS, R
    RABY, C
    CALLAHAN, MJ
    LIPINSKI, W
    SCHWARZ, R
    DUDLEY, DT
    LAUFFER, D
    REECE, P
    JAEN, J
    TECLE, H
    PROGRESS IN BRAIN RESEARCH, 1993, 98 : 439 - 445
  • [28] Serotonin Receptors as a Potential Target in the Treatment of Alzheimer's Disease
    Eremin, Dmitrii V.
    Kondaurova, Elena M.
    Rodnyy, Aleksander Ya.
    Molobekova, Camilla A.
    Kudlay, Dmitrii A.
    Naumenko, Vladimir S.
    BIOCHEMISTRY-MOSCOW, 2023, 88 (12-13) : 2023 - 2042
  • [29] Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease
    Dmitrii V. Eremin
    Elena M. Kondaurova
    Aleksander Ya. Rodnyy
    Camilla A. Molobekova
    Dmitrii A. Kudlay
    Vladimir S. Naumenko
    Biochemistry (Moscow), 2023, 88 : 2023 - 2042
  • [30] Ryanodine Receptors: A Potential Treatment Target in Various Neurodegenerative Disease
    Liang Sun
    Huafeng Wei
    Cellular and Molecular Neurobiology, 2021, 41 : 1613 - 1624
12345